Comparing risperidone and aripiprazole in ADHD
Not Applicable
- Conditions
- ADHD.Disturbance of activity and attention
- Registration Number
- IRCT2014041211983N2
- Lead Sponsor
- Shahrekord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
age of 3 to 6 years; affected with disruptive behavior disorders and ADHD based on DSM-IV criteria.
Exclusion criteria : mental retardation or other developmental disorders such as autism; chronic physical or neurologic diseases; treatment with other psychotropic medications; development of severe and untolerable medication side effects .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of ADHD and ODD symptoms. Timepoint: weeks 0, 2 , 4, and 8. Method of measurement: Short and Revised version of Conners Rating Scale parent form.;Rate of improvement. Timepoint: weeks 2, 4 and 8. Method of measurement: CGI-I scale.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: weeks 2, 4 and 8. Method of measurement: checklist.;Level of prolactine and fasting blood sugar. Timepoint: weeks 0 and 8. Method of measurement: lab data.;Body weight. Timepoint: weeks 0 and 8. Method of measurement: weight measurement.